1. Invasion:
- Initial Attachment: Shigella initially attaches to the surface of human epithelial cells through specific adhesins, such as IpaB, IpaC, and IpaD. These adhesins bind to receptors on the host cell surface, facilitating bacterial adherence.
- Triggering Host Cell Signaling: Shigella's attachment triggers signaling cascades within the host cell, leading to the reorganization of the actin cytoskeleton and membrane ruffling. This facilitates the formation of phagocytic cups that engulf the bacteria.
- Entry into Host Cell: Shigella exploits the phagocytic process by using a type III secretion system (T3SS) to inject effector proteins into the host cell. These effectors manipulate cellular processes, enabling the bacteria to enter and survive within the host cell.
2. Intracellular Replication:
- Formation of Intracellular Vacuole: Once inside the host cell, Shigella resides within a membrane-bound compartment called the spacious intracellular vacuole (SIV). This vacuole provides a protective environment for the bacteria and allows them to replicate.
- Exploiting Host Cell Resources: Shigella manipulates host cell processes to obtain nutrients and energy required for its growth and replication. It acquires host cell metabolites, scavenges iron, and disrupts cellular pathways to create a suitable intracellular environment for its survival.
3. Dysregulated Immune Response:
- Impaired Phagocytosis: Shigella's T3SS effector proteins interfere with the normal phagocytic and bactericidal functions of host cells, allowing the bacteria to evade intracellular killing.
- Activation of Pro-inflammatory Responses: Shigella infection triggers the production of pro-inflammatory cytokines and chemokines, leading to inflammation and recruitment of immune cells. However, the bacteria can manipulate these inflammatory responses to their advantage, disrupting the normal immune surveillance and promoting their survival.
- Immune Cell Evasion: Shigella can disseminate from infected cells to neighboring cells, avoiding host immune detection and establishing new sites of infection.
4. Host Cell Death and Tissue Damage:
- Cytotoxicity: Shigella infection can lead to host cell death through various mechanisms, including apoptosis, pyroptosis, and necrosis. These processes contribute to tissue damage and the clinical symptoms associated with shigellosis.
- Dysregulated Cell Signaling: Shigella's effector proteins disrupt host cell signaling pathways, affecting cell cycle regulation, cytoskeletal organization, and apoptosis. This dysregulation can further contribute to tissue damage and disease severity.
Understanding the intricate interplay between human cells and pathogenic Shigella is essential for developing targeted therapies that can effectively combat shigellosis while minimizing damage to host tissues. Further research is needed to unravel the molecular mechanisms underlying these interactions and identify potential therapeutic targets to improve the treatment outcomes of shigellosis.
